MS
EDIT icon

Murray Stahl’s Editas Medicine EDIT Stock Holding History

Murray Stahl’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.7K Sell
27,680
-1,330
-5% -$3.89K ﹤0.01% 325
2026
Q1 		$71.7K Sell
29,010
-1,330
-4% -$2.81K ﹤0.01% 332
2025
Q4 		$62.2K Sell
30,340
-1,330
-4% -$3.84K ﹤0.01% 318
2025
Q3 		$110K Buy
31,670
+1,280
+4% +$3.57K ﹤0.01% 323
2025
Q2 		$66.9K Sell
30,390
-1,330
-4% -$2.18K ﹤0.01% 341
2025
Q1 		$36.8K Hold
31,720
– – ﹤0.01% 341
2024
Q4 		$40.3K Buy
31,720
+1,330
+4% +$3.39K ﹤0.01% 343
2024
Q3 		$104K Sell
30,390
-1,330
-4% -$5.79K ﹤0.01% 327
2024
Q2 		$148K Hold
31,720
– – ﹤0.01% 296
2024
Q1 		$235K Hold
31,720
– – ﹤0.01% 271
2023
Q4 		$321K Sell
31,720
-1,330
-4% -$11.7K 0.01% 246
2023
Q3 		$258K Hold
33,050
– – 0.01% 259
2023
Q2 		$272K Hold
33,050
– – 0.01% 267
2023
Q1 		$240K Buy
+33,050
New +$294K ﹤0.01% 279
2022
Q1 		– Sell
-8,050
Closed -$214K – 348
2021
Q4 		$214K Hold
8,050
– – ﹤0.01% 322
2021
Q3 		$331K Buy
8,050
+50
+0.6% +$2.74K 0.01% 274
2021
Q2 		$453K Hold
8,000
– – 0.01% 250
2021
Q1 		$336K Hold
8,000
– – 0.01% 277
2020
Q4 		$561K Hold
8,000
– – 0.02% 224
2020
Q3 		$224K Hold
8,000
– – 0.01% 329
2020
Q2 		$237K Buy
+8,000
New +$209K 0.01% 318

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Murray Stahl's EDIT Position: Q2 2026 in Review

Murray Stahl reduced its Editas Medicine (EDIT) stake by 4.6% in Q2 2026, selling an estimated $3.89K and leaving 27,680 shares worth $89.7K. The position accounts for ﹤0.01% of the portfolio, ranked #325.

Murray Stahl first reported a position in EDIT in Q2 2020 and has held it in 21 quarters since. The position peaked at $561K in Q4 2020. 213 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Murray Stahl held 27,680 shares of Editas Medicine worth $89.7K as of Q2 2026.
  • Murray Stahl sold 1,330 Editas Medicine shares in Q2 2026, an estimated $3.89K.
  • Editas Medicine made up ﹤0.01% of Murray Stahl's portfolio in Q2 2026, its #325 holding.
  • Murray Stahl first reported a position in Editas Medicine in Q2 2020 and has held it in 21 quarters since.
  • Murray Stahl's Editas Medicine position peaked at $561K in Q4 2020.
  • 213 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.